S Jensen, A Pedersen, J Reibel, B Nauntofte - Supportive care in cancer, 2003 - Springer
This review presents data from the literature on oral adverse reactions from the perspectives of subjective feelings of dry mouth (xerostomia) and objective measures of salivary gland …
J Xiao, Y Moon, L Li, E Rustchenko, H Wakabayashi… - PloS one, 2016 - journals.plos.org
Introduction Candida albicans has been detected together with Streptococcus mutans in high numbers in plaque-biofilm from children with early childhood caries (ECC). The goal of …
N Aslani, G Janbabaei, M Abastabar, JF Meis… - BMC Infectious …, 2018 - Springer
Background Opportunistic infections due to Candida species occur frequently in cancer patients because of their inherent immunosuppression. The aim of the present study was to …
This study was to evaluate specific effects of photodynamic therapy (energy density 15.8 J/cm 2, 26.3 J/cm 2 and 39.5 J/cm 2) using methylene blue, toluidine blue and malachite …
CSP Tsang, FCS Chu, WK Leung… - Journal of medical …, 2007 - microbiologyresearch.org
The aim of this study was to biotype and characterize phospholipase, proteinase and haemolytic activities of oral Candida albicans isolates from 210 Chinese patients with type 2 …
LY Ann Chai, DW Denning, P Warn - Critical reviews in …, 2010 - Taylor & Francis
Candida tropicalis is one of the more common Candida causing human disease in tropical countries; the frequency of invasive disease varies by geography causing 3–66% of …
YH Samaranayake, LP Samaranayake… - Journal of Clinical …, 2001 - Am Soc Microbiol
ABSTRACT A variety of innate defense factors in saliva such as lysozyme and lactoferrin contribute to mucosal protection and modulate Candida populations in the oral cavity. It is …
Although the main reservoir of Candida spp. is believed to be the buccal mucosa, these microorganisms can coaggregate with bacteria in subgingival biofilm and adhere to …
M Panghal, V Kaushal, S Kadayan, JP Yadav - BMC Oral Health, 2012 - Springer
Background Over the past decade, advances in cancer treatments have been counterbalanced by a rising number of immunosuppressed patients with a multitude of new …